Vibha Ravi

@ScripVibhaRavi

Writer, Sub-Editor . Tweet global pharmaceutical, healthcare news. Views own

Vrijeme pridruživanja: listopad 2019.

Tweetovi

Blokirali ste korisnika/cu @ScripVibhaRavi

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ScripVibhaRavi

  1. Prikvačeni tweet
    prije 7 sati

    Zydus Cadila explores orphan drug indication for NASH candidate Saroglitazar Mg even as Q3 revenues see 1.8% YoY growth, pharma revenues drop 4%

    Poništi
  2. proslijedio/la je Tweet

    Drug Controller General of India approves 'restricted use' of combination of drugs used widely for controlling HIV infection in public health emergency for treating novel patients: Official sources

    Poništi
  3. prije 3 sata

    Lupin impairs intangible assets from Gavis acquisition, says led to exceptional loss of INR 15.8 bn (pretax) in Q3

    Poništi
  4. prije 7 sati

    Granules India gets USFDA approval for colchicine tablets 0.6 mg, bioequivalent to Takeda's Colcrys. Alkem, Dr. Reddy’s, Mylan, Watson are other players

    Poništi
  5. proslijedio/la je Tweet

    's effort to get smaller follows a growing industry trend among big pharmas to focus on select therapeutic areas and high-growth innovative brands. But Merck's decision came as a bit of a surprise; CEO Frazier said it was considered for some time.

    Poništi
  6. proslijedio/la je Tweet
    prije 17 sati

    Pharma Is Priority As GSK Confirms Split With Consumer

    Poništi
  7. proslijedio/la je Tweet
    5. velj
    Poništi
  8. proslijedio/la je Tweet
    5. velj

    splitting into two: 1. biopharma company focused on 'science related to the immune system, use of genetics and new technologies'. 2. leader in consumer healthcare.

    Poništi
  9. proslijedio/la je Tweet
    5. velj
    Poništi
  10. proslijedio/la je Tweet
    5. velj
    Poništi
  11. proslijedio/la je Tweet
    prije 9 sati
    Poništi
  12. 5. velj

    Panacea Biotec transfers pharmaceuticals business in slump sale to wholly-owned subsidiary Panacea Biotec Pharma Ltd

    Poništi
  13. proslijedio/la je Tweet
    5. velj
    Poništi
  14. proslijedio/la je Tweet
    4. velj
    Poništi
  15. proslijedio/la je Tweet
    4. velj
    Poništi
  16. 4. velj

    WHO FAQs on HFN1: Human cases of H5N1 avian influenza occasional, but difficult to transmit the infection from person to person. When people do become infected, mortality rate about 60%

    Poništi
  17. 4. velj

    Amid the Coronavirus crisis, H5N1 avian (bird) flu rears its head in Hunan, China

    Prikaži ovu nit
    Poništi
  18. 4. velj

    GSK offers adjuvant expertise to CEPI, companies developing vaccine for 2019-nCoV

    Poništi
  19. proslijedio/la je Tweet
    3. velj

    Ranitidine NDMA ( correcting typo) impact/ review ... GSK India will explore sale of Vemgal site ...

    Poništi
  20. 3. velj

    US FDA approval for first-ever food allergy therapy by Aimmune Therapeutics. What is the controversy though?

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·